Venus Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venus Remedies has informed the stock exchanges that its trading window will remain closed for all designated persons from July 1, 2025, until 48 hours after the declaration of audited financial results for the quarter ending June 30, 2025. This is a standard compliance measure required under SEBI's Prohibition of Insider Trading Regulations, 2015. The closure prevents insiders, including directors and key employees, from trading in the company's shares during the sensitive period around earnings announcement. The filing was signed by Neha, Company Secretary, on June 24, 2025.
This is a routine regulatory disclosure with no direct impact on shareholders or stock price. However, it signals that the company's Q1 FY26 audited results are expected to be announced shortly after June 30, 2025, which investors should watch for.